During the forecast period 2023 to 2033, the Renal insufficiency treatment market is expected to grow at a value of 5% CAGR, according to Future Market Insights. By the year 2033, the global market for Renal insufficiency treatment is expected to rise up to a market valuation of US$ 7.98 Billion. Growth of the market can be attributed to increasing prevalence of kidney diseases, a growing aging population, and technological advancements in renal insufficiency treatment.
According to the Centers for Disease Control and Prevention (CDC), more than 37 million people in the United States have kidney disease, and over 700,000 Americans are living with kidney failure, also known as end-stage renal disease (ESRD). In addition, kidney disease is a leading cause of death worldwide, with over 1.2 million deaths attributed to the disease in 2020 alone.
Find a comprehensive report summary that describes the market size and forecast along with the research methodology. The Sample report is available in PDF format @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16898
The increasing prevalence of kidney diseases is expected to drive the growth of the renal insufficiency treatment market, which includes a range of treatments for kidney failure and other renal disorders. These treatments include hemodialysis, peritoneal dialysis, kidney transplant, and medication.
Technological advancements in renal insufficiency treatment are also expected to drive the growth of the market. For example, the development of more advanced hemodialysis machines and catheters has made the procedure safer and more comfortable for patients, while the development of automated peritoneal dialysis machines has made peritoneal dialysis more accessible and convenient for patients.
Key Takeaways from the Market Study
- The global renal insufficiency treatment market is expected to grow with a 10.3% CAGR during 2023 to 2033.
- By end user, dialysis centres are expected to hold 45% of the market share in 2023 for Renal insufficiency treatment market.
- North America is expected to possess 48% market share for Renal insufficiency treatment market in 2023.
- Europe Renal insufficiency treatment market size is expected to possess 41% market share in 2023.
“An increasing prevalence of kidney diseases, a growing aging population, and technological advancements in renal insufficiency treatment.” states an FMI analyst
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16898
Competitive Landscape
Key players in the renal insufficiency treatment are Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., Medtronic Plc, Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., Cantel Medical, Nikkiso Co., Ltd., JMS Co. Ltd., AstraZeneca
- Nipro Corporation produces a range of peritoneal dialysis products, including the CAPD sets and cycler machines for automated peritoneal dialysis.
- Fresenius Medical Care produces a range of dialysis machines, dialyzers, bloodlines, and other equipment and supplies for use in hemodialysis and peritoneal dialysis treatment.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Renal insufficiency treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of Treatment Type (Dialysis, Medication, Kidney Transplantation) End User (Dialysis Centres, Hospital & Clinics, Research & Academic Institutes) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/16898
Key Segments Profiled in the Renal Insufficiency Treatment Industry Survey
Treatment Type:
- Dialysis
- Medication
- Kidney Transplantation
End User:
- Dialysis Centres
- Hospital & Clinics
- Research & Academic Institutes
About FMI:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
